Home » Topics » BioWorld Science

BioWorld Science
RSS

AstraZeneca initiates CALAVI study of Calquence against COVID-19

April 15, 2020

First-in-human data for telisotuzumab in advanced solid tumors

April 15, 2020

Dose-expansion phase I data for trastuzumab deruxtecan in multiple advanced cancers

April 15, 2020

Rejuvenating inflammation's end

April 15, 2020

The next pandemic: fire breaks and host-directed therapies

April 15, 2020

Lilly advances plans to evaluate baricitinib and LY-3127804 for COVID-19

April 14, 2020

AstraZeneca to unblind phase III ADAURA trial of Tagrisso early based on efficacy

April 14, 2020

BioInvent reports early responses in phase I/IIa study of BI-1206 for NHL

April 14, 2020

Bausch Health initiates clinical trial of Virazole in patients with COVID-19

April 14, 2020

PLOD1 mutation tied to smooth muscle cell dysfunction and aortopathy

April 14, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...